Flunarizine - CAS 52468-60-7
Catalog number: 52468-60-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C26H26F2N2
Molecular Weight:
404.50
COA:
Inquire
Targets:
Calcium Channel
Description:
Flunarizine is a selective calcium entry blocker, which has calmodulin binding properties and histamine H1 blocking activity. It may help to reduce the severity and duration of attacks of paralysis and is effective in rapid onset dystonia-parkinsonism. It is effective in the prophylaxis of migraine, vascular disease, occlusive peripheral, vertigo of central and peripheral origin. It is used as an adjuvant in the therapy of epilepsy. It has been shown to significantly reduce headache frequency and severity in both adults and children. It was discovered at Janssen Pharmaceutica in 1968. It has been listed.
Publictions citing BOC Sciences Products
  • >> More
Purity:
95%
Appearance:
Solid powder
Synonyms:
Sibelium;Flunarizinum;Flunarizina;(E)-1-[Bis-(p-fluorophenyl)methyl]-4-cinnamylpiperazine;1-[Bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]piperazine;Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)-, (E)-
Solubility:
Soluble in DMSO, not in water
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Flunarizine is effective in the prophylaxis of migraine, vascular disease, occlusive peripheral, vertigo of central and peripheral origin. It is used as an adjuvant in the therapy of epilepsy.
Quality Standard:
In-house standard
Quantity:
Kilograms to Tons
Boiling Point:
511.3±50.0 °C | Condition: Press: 760 Torr
Density:
1.170±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
SMANXXCATUTDDT-QPJJXVBHSA-N
InChI:
InChI=1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+
Canonical SMILES:
C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
Current Developer:
Flunarizine was discovered at Janssen Pharmaceutica in 1968. It has been listed.
1.[Neuropsychological deficits in alternating hemiplegia of childhood: a case study].
Muriel V1, Garcia-Molina A, Aparicio-Lopez C, Ensenat A, Roig-Rovira T. Rev Neurol. 2015 Jul 1;61(1):25-8.
in English, SpanishTITLE: Deficits neuropsicologicos en la hemiplejia alternante infantil: estudio de un caso.
2.INVESTIGATION AND OPTIMIZATION OF TITRIMETRIC AND SPECTROPHOTOMETRIC METHODS FOR THE ASSAY OF FLUNARIZINE DIHYDROCHLORIDE USING IN SITU BROMINE.
Prashanth KN, Swamy N, Basavaiah K. Acta Pol Pharm. 2016 Jan-Feb;73(1):35-45.
Three indirect methods for the assay of flunarizine dihydrochloride (FNH) in bulk drug and commercial formulation based on titrimetric and spectrophotometric techniques using bromate-bromide mixture are described. In titrimetry, a measured excess of bromate-bromide mixture is added to an acidified solution of FNH and the unreacted bromine is determined iodometrically (method A). Spectrophotometry involves the addition of a known excess of bromate-bromide mixture to FNH in acid medium followed by estimation of unreacted bromine by its reaction with excess iodide and the liberated iodine (I₃⁻) is either measured at 370 nm (method B) or liberated iodine reacted with starch followed by the measurement of the blue colored starch-iodide complex at 575 run (method C). Titrimetric method is applicable over the range 4.5-30.0 mg FNH (method A), and the reaction stoichiometry is found to be 1:2 (FNH:KBrO₃). The spectrophotometric methods are applicable over the concentration ranges 0.
3.Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties.
Pudukulatham Z1, Zhang FX2, Gadotti VM2, M'Dahoma S2, Swami P1, Tamboli Y1, Zamponi GW3. Mol Pain. 2016 Apr 6;12. pii: 1744806916641678. doi: 10.1177/1744806916641678. Print 2016.
BACKGROUND: T-type calcium channels are important contributors to signaling in the primary afferent pain pathway and are thus important targets for the development of analgesics. It has been previously reported that certain piperazine-based compounds such as flunarizine are able to inhibit T-type calcium channels. Thus, we hypothesized that novel piperazine compounds could potentially act as analgesics.
4.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.
Jackson JL1, Cogbill E2, Santana-Davila R3, Eldredge C4, Collier W5, Gradall A6, Sehgal N7, Kuester J1. PLoS One. 2015 Jul 14;10(7):e0130733. doi: 10.1371/journal.pone.0130733. eCollection 2015.
OBJECTIVE: To compare the effectiveness and side effects of migraine prophylactic medications.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Calcium Channel Products


CAS 144604-00-2 Diltiazem Malate

Diltiazem Malate
(CAS: 144604-00-2)

Diltiazem is a calcium channel antagonist. It can relax the smooth muscles in the walls of arteries, allow blood to flow more easily, and lower blood pressure. ...

CAS 52468-60-7 Flunarizine

Flunarizine
(CAS: 52468-60-7)

Flunarizine is a selective calcium entry blocker, which has calmodulin binding properties and histamine H1 blocking activity. It may help to reduce the severity...

CAS 123932-43-4 (R)-(+)-Nor Verapamil Hydrochloride

(R)-(+)-Nor Verapamil Hydrochloride
(CAS: 123932-43-4)

This active molecular is a chiral metabolite of Verapamil which is a calcium channel blocker applicated in the treatment of hypertension, angina pectoris, cardi...

CAS 60142-96-3 Gabapentin

Gabapentin
(CAS: 60142-96-3)

Gabapentin is structurally similar to GABA and is reported in various research studies to increase GABA concentrations within the brain. Gabapentin is also note...

CAS 261969-05-5 CALP3

CALP3
(CAS: 261969-05-5)

CALP3 is a cell-permeable calmodulin (CaM) agonist binding to the EF-hand/Ca2+-binding site. It activates phosphodiesterase in the absence of Ca2+ and suppresse...

CAS 106375-28-4 ω-Conotoxin GVIA

ω-Conotoxin GVIA
(CAS: 106375-28-4)

ω-Conotoxin GVIA is a peptide neurotoxin first isolated from the marine snail Conus geographus L. It selectively and reversibly blocks specific voltage-dependen...

CAS 1137264-00-6 cis-Ned 19

cis-Ned 19
(CAS: 1137264-00-6)

cis-Ned 19 is a irreversible nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist, which inhibits Ca2+ release (IC50 = 800 nM) and [32P]NAADP bindin...

CAS 132203-70-4 Cilnidipine

Cilnidipine
(CAS: 132203-70-4)

Cilnidipine is a unique L-type and N-type calcium channel blocker, used for high blood pressure treatment.

CAS 39562-70-4 Nitrendipine

Nitrendipine
(CAS: 39562-70-4)

Nitrendipine is a dihydropyridine calcium channel blocker with an IC50 of 95 nM.It is used in the treatment of primary (essential) hypertension to decrease bloo...

S(-)-BAY K 8644
(CAS: 98625-26-4)

S(-)-BAY K 8644 is an activator of voltage-sensitive L-type calcium channels with positive inotropic, vasoconstrictive and behavioral effects in vivo. It is the...

CAS 60142-95-2 Gabapentin hydrochloride

Gabapentin hydrochloride
(CAS: 60142-95-2)

Gabapentin HCl is a GABA analogue.Originally it was developed to treat epilepsy, and is currently used to relieve neuropathic pain and restless leg syndrome.

CAS 100427-26-7 Lercanidipine

Lercanidipine
(CAS: 100427-26-7)

Lercanidipine hydrochloride, a dihydropyridine compound, is a third generation calcium channel antagonist which shows longer duration of action of the past two ...

CAS 116308-56-6 Watanipidine monohydrochloride

Watanipidine monohydrochloride
(CAS: 116308-56-6)

Watanipidine, also called as AE 0047 or Calbren, is a calcium channel antagonist.

CAS 21829-25-4 Nifedipine

Nifedipine
(CAS: 21829-25-4)

Nifedipine is a dihydropyridine calcium channel blocker that primarily blocks L-type calcium channels.Its main uses are as an antianginal (especially inPrinzmet...

CAS 72509-76-3 Felodipine

Felodipine
(CAS: 72509-76-3)

Felodipine is a selective L-type Ca2+ channel blocker with IC50 of 0.15 nM. It can lower blood pressure by reducing peripheral vascular resistance via a highly ...

CAS 116644-53-2 Mibefradil

Mibefradil
(CAS: 116644-53-2)

Mibefradil, a calcium channel blocker, has modest selectivity for T-type Ca2+ channels so that could be used in the treatment of sorts of cardiovascular disease...

CAS 111011-63-3 EFONIDIPINE

EFONIDIPINE
(CAS: 111011-63-3)

Efonidipine could be effective in the treatment of cardiovascular disease as a blocker of T-type and L-type calcium channels. It could also present as the hydro...

CAS 77-41-8 METHSUXIMIDE

METHSUXIMIDE
(CAS: 77-41-8)

Mesuximide is a succinimide anticonvulsant medication. The therapeutic efficacy of methosuximide is due to its pharmacologically active metabolite, N-desmethylm...

CAS 111011-53-1 EFONIDIPINE HCL

EFONIDIPINE HCL
(CAS: 111011-53-1)

The hydrochloride salt form of Efonidipine which could be effective in the treatment of cardiovascular disease as a blocker of T-type and L-type calcium channel...

Ned K

Ned K, a NAADP inhibitor, prevents Ca2+ oscillations in rat cardiomyocytes in vitro during simulated ischemia and reperfusion, but exhibits no significant effec...

Chemical Structure

CAS 52468-60-7 Flunarizine

Quick Inquiry

Verification code

Featured Items